Shares of Boston Scientific rose 2.67% to $37.64 at 14:57 EST on Thursday, following last session’s upward trend. NYSE Composite is falling 0.36% to $15,042.87, after two sequential sessions in a row of gains. This seems, up to now, a somewhat rough trend trading session today.
Boston Scientific’s last close was $36.66, 17.43% under its 52-week high of $44.20.
News about Boston Scientific today
Boston Scientific to acquire preventice solutions for $925 million in cash, up to $300 million in potential milestone payments. According to today’s article on MarketWatch, "Cardiovascular disease is the leading cause of mortality globally, accounting for nearly 17.9 million annual global deaths and highlighting the need for early detection and management for individuals who may be at risk of a cardiac event," Boston Scientific said in a statement. "
Boston Scientific’s Sales
Boston Scientific’s sales growth is a negative 2.2% for the ongoing quarter and 7.4% for the next. The company’s growth estimates for the present quarter is a negative 32.6% and positive 25% for the next.
Boston Scientific’s last day, last week, and last month’s average volatility was 1.08%, 0.75%, and 0.17%, respectively.
Boston Scientific’s last day, last week, and last month’s high and low average amplitude percentage was 2.08%, 2.20%, and 2.15%, respectively.
Boston Scientific’s Stock Yearly Top and Bottom Value
Boston Scientific’s stock is valued at $37.64 at 14:57 EST, way under its 52-week high of $44.20 and way higher than its 52-week low of $24.10.
Boston Scientific’s Moving Average
Boston Scientific’s worth is above its 50-day moving average of $35.19 and above its 200-day moving average of $37.22.